Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Tanglewood Trail Walking Program in Rural Kentucky 2020: Complete Statistical AnalysisIndependent statistical analysis of Tanglewood Trail Walking Program in Rural Kentucky 2020: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05002985).
- TANGOIndependent statistical analysis of A Phase 3 Study of Tanezumab for Chronic Low Back Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TANGOIndependent statistical analysis of CER-001 Therapy as a Novel Approach to Treat Genetic Orphan Diseases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Tango for Neuropathy Among Breast Cancer Survivors: Complete Statistical AnalysisIndependent statistical analysis of Tango for Neuropathy Among Breast Cancer Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05114005).
- TAOATIndependent statistical analysis of Temporary Aortic Occlusion With the Abdominal Tourniquet for Refractory Postpartum Haemorrhage: A Proof-of-Concept Study in a War-Affected Region: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- TAPIndependent statistical analysis of Postoperative Pain Control for Prostatectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00913068).
- TAPIndependent statistical analysis of Transversus Abdominis Plane (TAP) Block Using Liposomal Bupivacaine in Metabolic and Bariatric Surgery Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- TAPIndependent statistical analysis of Trial Comparing Transversus Abdominis Plane Block Versus Epidural Anesthesia for Pain Management in Colorectal Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TAP Block With Liposomal Bupivacaine Versus Bupivacaine in Robotic Hysterectomy: Complete Statistical AnalysisIndependent statistical analysis of TAP Block With Liposomal Bupivacaine Versus Bupivacaine in Robotic Hysterectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02289079).
- TAP HYSIndependent statistical analysis of Transversus Abdominis Plane (TAP) Block Laparoscopic Hysterectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01074229).
- TAP-PIndependent statistical analysis of Can a Novel Telemedicine Tool Reduce Disparities Related to the Identification of Preschool Children With Autism?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- TAPASIndependent statistical analysis of TissuePAtchDS--P ™ PArotidectomy Trial.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04116762).
- TapBlockIndependent statistical analysis of Comparison of Exparel to Bupivacaine With Dexamethasone in TAP Block: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02179892).
- TAPEIndependent statistical analysis of Validation of the Mercy TAPE: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01507090).
- Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis: Complete Statistical AnalysisIndependent statistical analysis of Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- TAPERIndependent statistical analysis of Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal: primary endpoint results, effect estimate with confidence interval,…
- Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002): Complete Statistical AnalysisIndependent statistical analysis of Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03983980).
- TAPPASIndependent statistical analysis of Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TAPPASIndependent statistical analysis of Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients With Advanced Angiosarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC): Complete Statistical AnalysisIndependent statistical analysis of TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- TARDISIndependent statistical analysis of TARDIS - Photo Elicitation and Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06972251).
- TARDOXIndependent statistical analysis of Targeted Chemotherapy Using Focused Ultrasound for Liver Tumours: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02181075).
- TARGETIndependent statistical analysis of Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- TARGETIndependent statistical analysis of Role of On-site CT-derived FFR in the Management of Suspect CAD Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TARGET PASIndependent statistical analysis of TARGET Post-Approval Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02800863).
- TARGET-ANHIndependent statistical analysis of Biomarker and Thrombogenicity Assessment in Cardiopulmonary Bypass Surgery Utilizing Acute Normovolemic Hemodilution: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Targeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the Breast: Complete Statistical AnalysisIndependent statistical analysis of Targeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the Breast: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Targeted Pharmacological and Behavioral Treatments for Smoking in Schizophrenia Study 1: Complete Statistical AnalysisIndependent statistical analysis of Targeted Pharmacological and Behavioral Treatments for Smoking in Schizophrenia Study 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery: Complete Statistical AnalysisIndependent statistical analysis of Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Targeting Cellular Senescence With Senolytics to Improve Skeletal Health in Older Humans: Complete Statistical AnalysisIndependent statistical analysis of Targeting Cellular Senescence With Senolytics to Improve Skeletal Health in Older Humans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Targeting HIV Retention and Improved Viral Load Through Engagement (‘THRIVE’): Complete Statistical AnalysisIndependent statistical analysis of Targeting HIV Retention and Improved Viral Load Through Engagement ('THRIVE'): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04481373).
- Targeting IL-17A for Treatment-Resistant Depression: Complete Statistical AnalysisIndependent statistical analysis of Targeting IL-17A for Treatment-Resistant Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04979910).
- Targeting Reconsolidation to Prevent Return of Fear: Complete Statistical AnalysisIndependent statistical analysis of Targeting Reconsolidation to Prevent Return of Fear: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01623830).
- Targeting Right Ventricle in Pulmonary Hypertension Gilead: Complete Statistical AnalysisIndependent statistical analysis of Targeting Right Ventricle in Pulmonary Hypertension Gilead: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02829034).
- Targeting the Endothelial Glycocalyx to Enhance Vascular Function and Exercise-Induced Vascular Adaptations in Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Targeting the Endothelial Glycocalyx to Enhance Vascular Function and Exercise-Induced Vascular Adaptations in Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- TARGIT_BQRIndependent statistical analysis of TARGeted Intraoperative radioTherapy With INTRABEAM as a Boost for Breast Cancer - A Quality Control Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- TARGIT-DMIndependent statistical analysis of Targeted Adherence Intervention to Reach Glycemic Control With Insulin Therapy for Patients With Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- TARMICIndependent statistical analysis of Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly Trabectedin Combined With Metronomic Cyclophosphamide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma: Complete Statistical AnalysisIndependent statistical analysis of TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TAS-OX for Refractory Metastatic Colon Cancer: Complete Statistical AnalysisIndependent statistical analysis of TAS-OX for Refractory Metastatic Colon Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02848079).
- TAS3351Independent statistical analysis of A Study of TAS3351 in NSCLC Patients With EGFRmt: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05765734).
- TASALL – TachoSil® Against Liquor Leak: Complete Statistical AnalysisIndependent statistical analysis of TASALL - TachoSil® Against Liquor Leak: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01355627).
- TASCIndependent statistical analysis of Aortoiliac Stenosis in Kidney Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06020534).
- TASCIndependent statistical analysis of Transatlantic Active Surveillance on Cardiovascular Safety of NuvaRing (TASC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00524771).
- Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Taski-2Independent statistical analysis of Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TASKPENIndependent statistical analysis of Task-shifted Adaptation of the WHO-PEN Intervention to Address Cardio-metabolic Complications in People Living With HIV in Zambia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- TASTERIndependent statistical analysis of Ticagrelor Administered as Standard Tablet or Orodispersible Formulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03822377).
- TASvTVSIndependent statistical analysis of Transabdominal and Transvaginal Sonography in Medical Abortion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03047551).